MX336473B - Ensayo mediante adcc nk facs tridimensional. - Google Patents

Ensayo mediante adcc nk facs tridimensional.

Info

Publication number
MX336473B
MX336473B MX2012008950A MX2012008950A MX336473B MX 336473 B MX336473 B MX 336473B MX 2012008950 A MX2012008950 A MX 2012008950A MX 2012008950 A MX2012008950 A MX 2012008950A MX 336473 B MX336473 B MX 336473B
Authority
MX
Mexico
Prior art keywords
adcc
facs assay
aggregate
spheroid
antibodies
Prior art date
Application number
MX2012008950A
Other languages
English (en)
Other versions
MX2012008950A (es
Inventor
Andrea Challand
Christian Klein
Manfred Kubbies
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2012008950A publication Critical patent/MX2012008950A/es
Publication of MX336473B publication Critical patent/MX336473B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4915—Blood using flow cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Ecology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una tecnología analítica celular basada en un ensayo de cocultivo tridimensional de esferoides/agregado, donde el esferoide o el agregado se forman a partir de un tumor y linfocitos citolíticos espontáneos. Este método es útil para el análisis funcional in vitro de anticuerpos en formato individual y de alto rendimiento.
MX2012008950A 2010-02-11 2011-02-04 Ensayo mediante adcc nk facs tridimensional. MX336473B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10153277 2010-02-11
PCT/EP2011/051633 WO2011098402A1 (en) 2010-02-11 2011-02-04 3d adcc nk facs assay

Publications (2)

Publication Number Publication Date
MX2012008950A MX2012008950A (es) 2014-02-27
MX336473B true MX336473B (es) 2016-01-20

Family

ID=42169475

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008950A MX336473B (es) 2010-02-11 2011-02-04 Ensayo mediante adcc nk facs tridimensional.

Country Status (12)

Country Link
US (2) US20120309016A1 (es)
EP (1) EP2534480B1 (es)
JP (1) JP5719384B2 (es)
KR (1) KR101497196B1 (es)
CN (1) CN102741695B (es)
BR (1) BR112012016230A2 (es)
CA (1) CA2787157A1 (es)
ES (1) ES2459122T3 (es)
HK (1) HK1174392A1 (es)
MX (1) MX336473B (es)
RU (1) RU2577702C2 (es)
WO (1) WO2011098402A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10655107B2 (en) 2011-09-20 2020-05-19 Corning Incorporated Adherent cell culture method
US10883083B2 (en) 2013-08-02 2021-01-05 The Trustees Of Columbia University In The City Of New York Tissue-engineered three-dimensional model for tumor analysis
CN103712967B (zh) * 2013-12-27 2014-12-03 首都医科大学附属北京友谊医院 检测nk细胞活性的方法
US10597633B2 (en) 2014-05-16 2020-03-24 Koninklijke Nederlandse Akademie Van Wetenschappen Culture method for organoids
GB201421092D0 (en) 2014-11-27 2015-01-14 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium
GB201603569D0 (en) 2016-03-01 2016-04-13 Koninklijke Nederlandse Akademie Van Wetenschappen Improved differentiation method
KR101935989B1 (ko) 2017-01-18 2019-01-07 서강대학교산학협력단 하이드로젤 마이크로웰을 이용한 멀티셀룰라 스페로이드의 제조 방법
AU2019215096A1 (en) * 2018-02-02 2020-08-06 Wake Forest University Health Sciences Organoids related to immunotherapy and methods of preparing and using the same
CN118401673A (zh) * 2021-12-06 2024-07-26 上海药明生物技术有限公司 用于测量抗体依赖性细胞介导的细胞毒性的3d生物测定

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302435A1 (en) * 1987-07-31 1989-02-08 Neorx Corporation Method for augmenting antibody-dependent cellular cytotoxicity
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
CA2451185A1 (en) * 2001-06-21 2003-01-03 Altus Biologics, Inc. Spherical protein particles and methods of making and using them
EP1648507B1 (en) * 2003-07-24 2017-01-25 Innate Pharma S.A. Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds
LT2348051T (lt) 2003-11-05 2019-02-25 Roche Glycart Ag Cd20 antikūnai su padidintu fc receptoriaus prisijungimo giminingumu ir efektorine funkcija
ATE477486T1 (de) * 2006-01-04 2010-08-15 Novartis Ag Antikörperabhängiger zellulärer zytotoxizitätstest
JP5282040B2 (ja) * 2007-09-28 2013-09-04 オリンパス株式会社 Ｆｃ受容体遺伝子導入ＮＫ細胞を用いた抗体依存性細胞傷害のアッセイ方法

Also Published As

Publication number Publication date
RU2577702C2 (ru) 2016-03-20
JP5719384B2 (ja) 2015-05-20
CN102741695A (zh) 2012-10-17
ES2459122T3 (es) 2014-05-08
MX2012008950A (es) 2014-02-27
US20120309016A1 (en) 2012-12-06
KR20120125369A (ko) 2012-11-14
BR112012016230A2 (pt) 2019-09-24
US20160252493A1 (en) 2016-09-01
JP2013519360A (ja) 2013-05-30
EP2534480A1 (en) 2012-12-19
US10330669B2 (en) 2019-06-25
CN102741695B (zh) 2015-08-26
CA2787157A1 (en) 2011-08-18
RU2012138554A (ru) 2014-03-20
KR101497196B1 (ko) 2015-02-27
WO2011098402A1 (en) 2011-08-18
EP2534480B1 (en) 2014-03-19
HK1174392A1 (zh) 2013-06-07

Similar Documents

Publication Publication Date Title
MX336473B (es) Ensayo mediante adcc nk facs tridimensional.
AU2019268194A1 (en) Cell culture system
MX353144B (es) Proteinas que contienen fc de anticuerpos heterodimericos y metodos para produccion de las mismas.
MX2012009175A (es) Metodos para identificar y aislar celulas que expresan un polipeptido.
MY181513A (en) Cell culture compositions and methods for polypeptide production
MX2010008099A (es) Anticuerpos y angiopoyetina-2 estabilizados y sus usos.
MY162752A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
MY161866A (en) Cell culture improvements
MX2008014692A (es) Metodo de cultivo para obtener una poblacion clonal de celulas b especificas de antigeno.
SG193006A1 (en) Interrogatory cell-based assays and uses thereof
EP2346984A4 (en) PERFUSION BIOREACTOR, CELL CULTURE SYSTEMS AND METHODS FOR PRODUCING CELLS AND CELL DERIVED PRODUCTS
MX2014006570A (es) Cocteles de enzimas preparados a partir de cultivos mezclados.
WO2015004403A3 (fr) Procede de culture cellulaire decouple
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
IN2014DN11272A (es)
EP3524672A3 (en) Reprogramming cancer cells
GB201021499D0 (en) Detection of quantative genetic differnces
MX2013011355A (es) Metodo de produccion de polipeptido recombinante.
WO2011085157A3 (en) Methods for in vitro oocyte maturation
EP2262834A4 (en) ANTIBODIES THAT IMITATE L-CELL RECEPTORS AND METHODS OF MAKING AND USING SAME
BR112015014328A2 (pt) Célula de mamífero capaz de propagar arterivírus, cultura celular, e, método para a propagação de um arterivírus em cultura celular
WO2011150418A3 (en) Compositions and methods for treating pathologies
AU2016219622A1 (en) Heterodimeric antibody FC-containing proteins and methods for production thereof
CL2016000874A1 (es) Anticuerpos anti-cd38 (divisional de sol. 1944-13).
WO2011157896A3 (en) Induced proteins